Safety of pacemaker and implantable cardioverter–defibrillator implantation during uninterrupted warfarin treatment — The FinPAC study

Conclusion: Our randomized study demonstrates that CRM devices can be safely implanted without discontinuation of warfarin treatment.

Source: International Journal of Cardiology - July 11, 2013 Category: Cardiology Authors: K.E. Juhani Airaksinen, Petri Korkeila, Juha Lund, Antti Ylitalo, Pasi Karjalainen, Vesa Virtanen, Pekka Raatikainen, Ulla-Maija Koivisto, Juhani Koistinen Tags: Original Articles Source Type: research